Table 1.

Characteristics of vWD samples subsequently tested by FCS.

Sample	Antigen, %	RCoF, %	Factor VIII, %	Multimer analysis	Type
1	44	44	43	All multimers present in decreased amounts	Type 1
2	43	28	38	All multimers present in decreased amounts	Type 1
3	43	40	53	All multimers present in decreased amounts	Type 1
4	45	42	73	All multimers present in decreased amounts	Type 1
5	39	<20	42	All multimers present in decreased amounts	Type 1/2M
6	13	<20	13	All multimers present in decreased amounts	Type 1
7	43	40	63	All multimers present in decreased amounts	Type 1
8	15	<20	48	All multimers present in decreased amounts	Type 1
9	48	48	69	All multimers present in decreased amounts	Type 1
10	37	26	26	All multimers present in decreased amounts	Type 1
11	38	42	78	All multimers present in decreased amounts	Type 1
12	32	25	37	All multimers present in decreased amounts	Type 1
13	68	<20	14	No large or intermediate multimers	Severe type 2A
14	31	<20	39	Absence of large multimers	Type 2A
15	19	<20	39	Absence of large multimers	Type 2A
16	50	<20	41	Absence of large multimers	Acquired type 2
17	21	<20	31	Absence of large multimers	Type 2A
18	17	<20	31	Absence of largest multimers	Type 2A
19	41	<20	103	Absence of largest multimers	Mild type 2A
20	77	35	65	Absence of large multimers	Acquired Type 2
21	38	18	29	Absence of large multimers	Type 2A
22	51	28	72	Absence of large multimers	Acquired type 2?
23	31	<20	39	Absence of large multimers	Type 2A
24	100	39	74	Absence of large multimers	Type 2
25	146	62	132	Absence of large multimers	Acquired type 2
26	188	121	112	Absence of largest multimers	Mild acquired type 2